Introduction
============

Management of pyogenic vertebral osteomyelitis (PVO) is a challenging problem in spite of advances in imaging, diagnostic, and treatment modalities. The incidence of pyogenic infection in the literature is approximately 1:250,000, and there is a recent trend toward an increase in the incidence of infection \[[@b1-asj-2018-0093],[@b2-asj-2018-0093]\]. The incidence of culture-negative PVO was 0.3--1.8 cases per 100,000 \[[@b3-asj-2018-0093]\]. Regardless of the treatment protocol, identification of the causative organism is crucial for selecting the antibiotic regime. Although surgical debridement helps in de-bulking the bacterial load, the need for antibiotic administration for preventing recurrence of the disease is paramount. Establishing a definitive diagnosis and managing the disease may be difficult when the culture specimen does not grow specific pathogens during histopathological examination suggestive of pyogenic infection. There are many reports describing the management and outcome of culture-positive PVO. However, there are few reports that describe the antibiotic protocol or functional outcome of culture-negative PVO. The aim of this study was to analyze the antibiotic protocols and functional and radiological outcomes in patients with hematogenous culture-negative PVO.

Materials and Methods
=====================

This study was approved by the institutional review board of Christian Medical College, Vellore, India (IRB Min no., 10216). Informed consent obtained from all patients. The study was conducted at a tertiary care spine referral center. We included patients who were pus culture-negative with histopathological features suggestive of PVO (i.e., spicules of necrotic bone with trabeculae of cortical and cancellous bone with marrow replaced by inflammatory granulation tissue comprising mild to moderate infiltrates of plasma cells, lymphocytes, eosinophils, and neutrophils with no granulomas). The patients were either treated conservatively or surgically from January 2005 to December 2015.

We retrospectively analyzed online medical records, patient charts, operative notes, radiographs, and discharge summaries. Patient demographic data, comorbidities, coexisting infections, level of spine involvement, pretreatment neurological status, and prior antibiotic therapy were documented. Inflammatory markers, such as erythrocyte sedimentation rate (ESR), total leukocyte count, and C-reactive protein (CRP), were documented pre- and postoperatively. Blood and urine culture, echocardiography for cardiac vegetations, and ultrasonography to look for intrapelvic abscess were performed. Our indications for surgery were progressive neurological deficit, mechanical instability, pain that did not subside with analgesics, and failed computed tomography (CT)-guided biopsy. Tissue samples were obtained by either CT-guided biopsy or open biopsy. The Visual Analog Scale (VAS) score, the Oswestry Disability Index (ODI), and the Japanese Orthopedics Association (JOA) score were documented preoperatively and on subsequent follow-up. At final follow-up, radiological imaging to assess fusion and healing status was performed, in addition to obtaining clinical scores.

Categorical variables were expressed as frequencies and percentages. Continuous variables were summarized as means and standard deviations. Pre- and postoperative ODI, JOA, and VAS scores were compared by the Wilcoxon signed rank test, as the distribution was not symmetric. A *p*-value \<0.05 was considered to indicate statistical significance. The data were analyzed with the SPSS ver. 17.0 (SPSS Inc., Chicago, IL, USA).

Results
=======

A total of 61 patients were included in the study, of whom 43 (71%) were males. The mean age was 53.2±1.7 years. Twelve patients (19%) were lost to follow-up, and four patients (6%) died from unassociated medical conditions after completion of treatment. Thus, complete follow-up was possible on 45 patients (73%). Forty-one patients (77%) had comorbidities. Forty-eight patients (79%) had symptoms for less than 2 months. Thirty-one patients (51%) did not report any previous source of infection. Prior to presentation, 20 patients (32%) had received an initial course of antibiotics from the primary treating physician. Fifteen (24%), 11 (18%), and five patients (8%) underwent blood culture, urine culture, and echocardiography, respectively. Baseline characteristics of the patients are presented in [Table 1](#t1-asj-2018-0093){ref-type="table"}. The radiological findings and levels of spine involvement are shown in [Tables 2](#t2-asj-2018-0093){ref-type="table"} and [3](#t3-asj-2018-0093){ref-type="table"}, respectively. Nineteen patients (31%) had neurological deficits at presentation; 12 of these 19 patients (63%) were available for final follow-up, and all recovered from the deficit ([Table 4](#t4-asj-2018-0093){ref-type="table"}). Forty-one patients (67%) had CT-guided biopsy. Thirty-one patients (51%) had surgical treatment with instrumented fusion, and 30 patients (49%) had conservative treatment based on the report from CT-guided biopsy. Forty-two patients (70%) were started empirically on antibiotics. Twelve (19%) and seven patients (11%) were started on antibiotics on the basis of culture from other remote foci or discussion with an infectious disease specialist, respectively.

The mean duration of follow-up was 18 months, with a range of 12--120 months. Forty-five patients (73%) were available for the final follow-up. The mean preoperative ODI score was 44.2±1.5; the mean postoperative score dropped significantly to 11.9±33 (*p*\<0.001). Similarly, the JOA and VAS scores showed significant improvement between the pre- and postoperative period (*p*\<0.001 for both comparisons) ([Table 5](#t5-asj-2018-0093){ref-type="table"}). The mean preoperative ESR and CRP levels were 55 mm/hr (range, 40 to 82.5 mm/hr) and 40 mg/L (range, 25 to 60.5 mg/L), respectively. The ESR and CRP levels also dropped significantly in the postoperative period to 17 mm/hr (range, 10 to 25 mm/hr) and 3 mg/L (range, 3 to 5 mg/L), respectively. All patients had clinical and radiological bony fusion at the final follow-up, as assessed by two independent surgeons. Case illustrations of one patient were described in [Figs. 1](#f1-asj-2018-0093){ref-type="fig"}--[](#f2-asj-2018-0093){ref-type="fig"}[](#f3-asj-2018-0093){ref-type="fig"}[](#f4-asj-2018-0093){ref-type="fig"}[](#f5-asj-2018-0093){ref-type="fig"}[6](#f6-asj-2018-0093){ref-type="fig"}. One patient had persistent sinus at the lower back. One patient had screw cut-out into the superior disk space, although the infected segment united well. Implant removal has been planned for this patient. One patient had persistent pain due to mechanical instability after completion of 3 months of empirical antibiotics. After evaluation, he underwent posterior instrument fusion, followed by the same empirical antibiotics, which went on to union.

Discussion
==========

This series describes the antibiotic protocol and the functional and radiological outcomes of culture-negative, biopsy-positive PVO. The current cohort of patients showed significant improvements in VAS, functional outcomes such as JOA and ODI, and good radiological union. All patients were empirically treated with first-generation antibiotics. The most commonly involved spine level was the lumbar (54%) followed by the thoracic (25%), lumbosacral (18%), and cervical (4%) levels, a finding similar to those in other published studies of PVO \[[@b4-asj-2018-0093]\]. Fifty-one percent of patients underwent surgical debridement and posterior instrumented fusion, and 49% were treated conservatively with antibiotics alone. Thirty-two percent of patients had neurological deficits preoperatively, and the functional neurology of all patients was improved at the final follow-up. Five percent of patients had bowel and bladder involvement and had regained splenetic function at the final follow-up.

An inconclusive microbiological pus culture report is a dilemma for the treating surgeon. A number of reasons for this culture-negative status in biopsy-proven infection can be suggested. One possibility is that the infection has been partially treated. Kim et al. \[[@b5-asj-2018-0093],[@b6-asj-2018-0093]\] in their retrospective analysis of 53 patients with pyogenic osteomyelitis suggested that patients who received antibiotics prepresentation were most likely to have negative cultures. Our institution is a tertiary care referral hospital, with a mean delay in presentation of all patients of approximately 2 months. During this period, 20 patients (32%) were administered antibiotics by their primary treating physician. This treatment reduces the likelihood of isolating the organism. The other factor could be the technique of retrieving the tissue sample. Because of the availability of a relatively large volume of tissue in open surgeries, there is a higher likelihood of identifying the organism. The limitation of CT-guided biopsy is that it yields a relatively small volume of tissue. The reported accuracy of CT-guided spinal bone biopsy is 50% to 90% \[[@b7-asj-2018-0093]-[@b9-asj-2018-0093]\]. In our institution, the majority of patients clinically suspected to have a spinal infection will undergo CT-guided biopsy.

To our knowledge, there is no standard guideline available for treating this unique set of patients. Cultures from other foci of infection, such as blood and urine, could guide in the selection of appropriate antibiotics. Discussion with the infectious diseases department can also guide in antibiotic selection. When these options are not available, antibiotics are selected empirically. Bhagat et al. \[[@b10-asj-2018-0093]\] compared and discussed the clinical presentation and biochemical markers and outcomes in culture-positive and culture-negative patients, but they did not discuss the usage of specific antibiotics. Seyman et al. \[[@b11-asj-2018-0093]\] retrospectively analyzed 15 patients with culture-negative PVO treated with tigecycline. They suggested that tigecycline is the drug of choice for this group of patients. However, the cost is prohibitive. In our series, we advocated treatment with 2 weeks of intravenous antibiotics and 10 weeks of oral antibiotics from our previous experience in treating pyogenic infection \[[@b12-asj-2018-0093]\]. During the initial 2 weeks, all patients were treated with high-end intravenous antibiotics either empirically or based on previous culture from any other focus. The initial aggressive treatment was implantation in situ, and patients receiving conservative treatment were given cloxacillin/cefazolin and one fluoroquinolone (ciprofloxacin). This was followed by 10 weeks of oral antibiotics, consisting of cloxacillin/cephalexin for grampositive coverage and ciprofloxacin for gram-negative coverage. No significant drug-related complications were noted.

Kim et al. \[[@b13-asj-2018-0093]\] conducted a retrospective review of patients with culture-positive and culture-negative PVO. They demonstrated that culture-negative PVO has fewer underlying associated medical comorbidities and fewer indicators of inflammatory response. However, they did not report functional and radiological outcomes in this study population. Furthermore, Kim et al. \[[@b13-asj-2018-0093]\] included patients who had had previous spinal procedures, and hence they studied a heterogeneous cohort. The distribution of organisms would be variable in a heterogeneous group. In our series, we included only patients with PVO of hematogenous origin.

In the workup of PVO, blood and urine cultures have been recommended as a guide for antibiotic selection. In the absence of signs of systemic sepsis, such as fever and leukocytosis, and the absence of specific signs and symptoms, the need for this investigation is questionable. Looking for primary foci of infection in the absence of signs and symptoms would increase the financial burden on the patient. In our series, 15 patients (24%) underwent blood culture, and only six of these (40%) grew an organism from the blood that was treated with sensitive antibiotics. Blood culture was performed in a patient who presented with systemic sepsis. Our blood culture positivity rate is comparable with that in the published literature \[[@b8-asj-2018-0093],[@b14-asj-2018-0093],[@b15-asj-2018-0093]\].

A limitation of this study was that 12 of 61 patients were lost to follow-up. Another limitation was that most patients did not undergo blood or urine culture as part of the evaluation of PVO. However, strength of the study is that it is the first series that reports the antibiotic protocol for this cohort of patients with a long follow-up. The functional and radiological outcomes have not been reported for this group so far.

Conclusions
===========

Culture-negative, biopsy-positive PVO is a challenging, uncommon, and underreported condition. There are no standard antibiotic guidelines available for the treatment of this group of patients. Treatment with empirical antibiotics for 12 weeks with watchful clinical and radiological follow-up yields good resolution of the disease. Further multicenter clinical research needs to be done to obtain an algorithmic treatment plan for these patients.
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###### 

Baseline characteristics

  Characteristic       No. (%)
  -------------------- -----------
  Sex                  
   Male                43 (70.5)
   Female              18 (29.5)
  Comorbidities        
   None                20 (32.8)
   Diabetes mellitus   25 (41.0)
   Liver disease       1 (1.6)
   Kidney disease      4 (6.6)
   Others              11 (18.0)
  Smoking              
   Yes                 9 (14.8)
   No                  52 (85.2)
  Alcohol              
   Yes                 3 (4.9)
   No                  58 (95.1)

###### 

Radiological findings among the patients

  Radiological finding                  No. (%)
  ------------------------------------- -----------
  X-ray features                        
   Vertebral erosion                    38 (62.3)
   Vertebral collapse                   18 (29.5)
   Other findings                       5 (8.0)
  Magnetic resonance imaging findings   
   Epidural abscess                     21 (34.4)
   Disk space collapse                  37 (60.7)
   Others                               3 (4.9)

###### 

Levels of spine involvement

  Level of spine involvement   No. (%)
  ---------------------------- -----------
  Cervical                     2 (3.3)
  Thoracolumbar                15 (24.6)
  Lumbar                       33 (54.1)
  Lumbosacral                  11 (18.0)

###### 

Preoperative and postoperative neurological pattern

  Frankel grade   Preoperative   Postoperative
  --------------- -------------- ---------------
  A               0              0
  B               0              0
  C               3              0
  D               12             0
  E               30             45
  Total           45             45

###### 

Preoperative and postoperative functional outcome measure

  Variable                                 Preoperative   Postoperative   *p*-value
  ---------------------------------------- -------------- --------------- -----------
  Visual Analog Scale score                7.7±0.8        3.3±0.6         \<0.001
  Oswestry Disability Index score          44.2±1.5       11.8±3.4        \<0.001
  Japanese Orthopedics Association score   7.8±2.3        25.6±1.9        \<0.001

Values are presented as mean±standard deviation.
